Cite
MLA Citation
Till Spreemann et al.. “First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension.” Pulmonary circulation, vol. 8, 2018, p. . http://access.bl.uk/ark:/81055/vdc_100072596523.0x000024